Emcure Pharmaceuticals IPO last bidding date is today. Should you subscribe Check GMP, subscription status, and critical dates.

Emcure Pharmaceuticals IPO last bidding date is today. Should you subscribe? Check GMP, subscription status, and critical dates.

Emcure Pharmaceuticals IPO subscription status: On the third day of bidding, the whole share of the Emcure Pharma IPO was oversubscribed, with non-institutional investors taking the lead. According to BSE data, the subscription status for Emcure Pharmaceuticals IPO is 11.63 times as of 13:00 IST. Non-institutional investors subscribed 31.67 times, with retail investors booking 5.36…

Read More
Emcure Pharmaceuticals IPO Day 2: GMP, subscription status, and review of allotment date. Apply or not?

Emcure Pharmaceuticals IPO Day 2: GMP, subscription status, and review of allotment date. Apply or not?

Emcure Pharmaceuticals IPO: Bidding for the initial public offering (IPO) began on July 3, 2024, and will stay open until July 5, 2024. This implies the public issue will be open until Friday this week. Emcure Pharmaceuticals’ IPO price ranges from ₹960 to ₹1008 per equity share. According to the Emcure Pharmaceuticals IPO subscription status,…

Read More